Porous Bioceramics Produced by Impregnation of 3D‐Printed Wax Mold: Ceramic Architectural Control and Process Limitations
Source abstract
Abstract
Current architectural and production limitations prevent the manufacturing standardization and design of bioceramics. Such limitations have hindered advances in bone tissue engineering and regeneration. In this context, we propose a bioceramic manufacturing process based on the impregnation of wax molds produced by additive manufacturing. Hydroxyapatite bioceramics with custom architectures were fabricated to evaluate the reliability, robustness, and limitations of this process. Results indicate that this process preserves phase biocompatibility, permits homogeneous shrinkage of the biomaterial during heat treatment, and allows reproducible and precise manufacturing of custom architectures.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · Bone Tissue Engineering Materials · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ecole Nationale Supérieure des Mines de Saint‐Etienne CIS‐EMSE INSERM U1059 SAINBIOSE F‐42023 Saint‐Etienne France
References (44)
Show source-provided references
1. 10.1308/rcsann.2006.88.3.334a10.1308/rcsann.2006.88.3.334a ↗
2. 10.1016/j.colsurfb.2010.05.04010.1016/j.colsurfb.2010.05.040 ↗
3. 10.1089/ten.teb.2013.068210.1089/ten.teb.2013.0682 ↗
4. 10.1007/BF0012489010.1007/BF00124890 ↗
5. 10.1016/j.bone.2005.06.01810.1016/j.bone.2005.06.018 ↗
6. 10.1016/j.biomaterials.2005.08.01610.1016/j.biomaterials.2005.08.016 ↗
7. 10.1016/j.biomaterials.2008.12.06810.1016/j.biomaterials.2008.12.068 ↗
8. 10.1016/j.jeurceramsoc.2007.05.02510.1016/j.jeurceramsoc.2007.05.025 ↗
9. 10.1016/j.ceramint.2007.01.00410.1016/j.ceramint.2007.01.004 ↗
10. 10.1089/ten.tea.2009.049410.1089/ten.tea.2009.0494 ↗
11. 10.1016/j.msec.2012.09.01310.1016/j.msec.2012.09.013 ↗
12. 10.1007/s11837-011-0063-910.1007/s11837-011-0063-9 ↗
13. 10.3990/1.978903653019410.3990/1.9789036530194 ↗
14. 10.1016/j.cirp.2007.10.00410.1016/j.cirp.2007.10.004 ↗
15. 10.1016/j.actbio.2009.12.04110.1016/j.actbio.2009.12.041 ↗
16. 10.1016/j.actbio.2012.11.02910.1016/j.actbio.2012.11.029 ↗
17. 10.1111/j.1551-2916.2006.01382.x10.1111/j.1551-2916.2006.01382.x ↗
18. 10.1002/jbm.a.3158710.1002/jbm.a.31587 ↗
19. 10.1002/jbm.a.3107210.1002/jbm.a.31072 ↗
20. 10.1016/j.actbio.2010.09.03910.1016/j.actbio.2010.09.039 ↗
21. 10.1088/1758-5082/6/1/01500610.1088/1758-5082/6/1/015006 ↗
22. Kumar A. · J. Biomater. Appl · 2015 · 8 · 1168
23. 10.1016/j.mser.2016.01.00110.1016/j.mser.2016.01.001 ↗
24. a)C.Chaput T.Chartier J.Brie J.Lafon Proceedings of the 4th International Congress on Ceramics The American Ceramic Society Hilton North Raleigh‐Midtown NC USA2012;
25. 10.1016/j.jcms.2012.11.00510.1016/j.jcms.2012.11.005 ↗
26. 10.1023/B:JMSM.0000011812.08185.2a10.1023/B:JMSM.0000011812.08185.2a ↗
27. 10.1007/s00366-015-0407-010.1007/s00366-015-0407-0 ↗
28. Chartier T. · Ceram. Forum Int · 2006 · 83 · 102
29. Brunello G. · Biotechnol. Adv · 2016
30. 10.1007/0-387-34403-9_9910.1007/0-387-34403-9_99 ↗
31. 10.1088/0957-4484/22/28/28570310.1088/0957-4484/22/28/285703 ↗
32. 10.1002/bab.106410.1002/bab.1064 ↗
33. 10.1016/j.matchar.2012.12.00910.1016/j.matchar.2012.12.009 ↗
34. C.Colin J.‐D.Bartout E.Shaker D.Marchat D.Nimal US Patent 20 160 052 162 2016.
35. 10.1002/adhm.20150016810.1002/adhm.201500168 ↗
36. 10.1371/journal.pone.003633610.1371/journal.pone.0036336 ↗
37. 10.1098/rsif.2008.006410.1098/rsif.2008.0064 ↗
38. 10.1002/jbm.a.2001510.1002/jbm.a.20015 ↗
39. 10.1007/s10856-010-4153-y10.1007/s10856-010-4153-y ↗
40. 10.1007/s10856-007-3045-210.1007/s10856-007-3045-2 ↗
41. Charbonnier B. · J. Eur. Ceram. Soc · 2016
42. 10.1016/j.jmatprotec.2006.03.12010.1016/j.jmatprotec.2006.03.120 ↗
43. 10.1115/1.402403510.1115/1.4024035 ↗
44. 10.1007/978-1-4419-1120-910.1007/978-1-4419-1120-9 ↗